Dataset Viewer
Auto-converted to Parquet Duplicate
drug
stringlengths
5
63
name_type
class label
2 classes
sentence
stringlengths
58
179
Abilify
0brand
We plan to start Abilify at ten milligrams daily to help manage the patient's schizophrenia symptoms effectively.
Adquey
0brand
Adquey works as a topical phosphodiesterase-4 inhibitor to help clear lesions associated with mild to moderate atopic dermatitis.
Advair
0brand
We are starting the patient on Advair twice daily because combining an inhaled corticosteroid with a LABA will better control her asthma symptoms.
Advil
0brand
I recommend taking Advil to help relieve the minor pain from your arthritis, but do not exceed six caplets daily.
Alhemo
0brand
We will initiate daily subcutaneous Alhemo to target Tissue Factor Pathway Inhibitor and improve clot formation in this hemophilia patient.
Alyftrek
0brand
Before starting Alyftrek, we need to confirm that the patient has at least one responsive CFTR gene variant.
Ambelvist
0brand
Before starting the scan, we will administer Ambelvist as an intravenous injection followed immediately by a normal saline flush.
Ambien
0brand
Because Ambien functions as a GABA A receptor positive modulator, it should effectively help manage your acute insomnia when taken at bedtime.
Anktiva
0brand
We are initiating Anktiva as an intravesical IL-15 receptor agonist alongside BCG for this patient with non-muscle invasive bladder cancer.
Aspirin
0brand
I recommend taking this coated Aspirin with plenty of water to help manage your minor aches and pains throughout the day.
Attruby
0brand
We should start the patient on Attruby to manage their transthyretin-mediated amyloid cardiomyopathy and reduce the risk of cardiovascular hospitalization.
Aucatzyl
0brand
Before we administer the intravenous infusion of Aucatzyl, let's verify that the patient has completed their lymphodepleting chemotherapy regimen.
Avlayah
0brand
We should start the pediatric patient on weekly Avlayah infusions to manage Hunter syndrome following the recommended dose escalation schedule.
Awiqli
0brand
By activating the insulin receptor, Awiqli effectively stimulates peripheral glucose uptake across the full seven-day dosing interval.
Baxfendy
0brand
We can add Baxfendy to your current blood pressure regimen to target aldosterone synthase and better manage your hypertension.
Benadryl
0brand
You can administer Benadryl to help relieve your child's sneezing and runny nose caused by upper respiratory allergies.
Beqalzi
0brand
Starting the patient on Beqalzi should help trigger apoptosis by selectively targeting the overexpressed BCL-2 protein.
Biktarvy
0brand
We can initiate Biktarvy once daily as a complete antiretroviral regimen to effectively manage the patient's HIV-1 infection.
Bizengri
0brand
Because the biopsy confirmed an NRG1 fusion, we will initiate Bizengri, which functions as a bispecific antibody targeting HER2 and HER3.
Blujepa
0brand
Make sure the patient takes Blujepa with food to treat her uncomplicated urinary tract infection while minimizing gastrointestinal intolerance.
Byetta
0brand
We will start Byetta before your two main meals because this GLP-1 receptor agonist helps manage your type 2 diabetes.
Bysanti
0brand
We should gradually titrate Bysanti twice daily to help control your manic episodes while minimizing any risk of orthostatic hypotension.
Casgevy
0brand
Before we administer the Casgevy infusion, we must complete the patient's full myeloablative conditioning regimen and ensure seizure prophylaxis is in place.
Chantix
0brand
We can initiate Chantix as a partial agonist to help curb withdrawal symptoms and support your smoking cessation attempt.
Claritin
0brand
You can take Claritin chewable tablets daily to help relieve your sneezing and itchy eyes from seasonal hay fever.
Cobenfy
0brand
Before starting Cobenfy for schizophrenia, let's check baseline liver enzymes and ensure the patient takes it on an empty stomach.
Cosentyx
0brand
We should start the patient on Cosentyx to selectively inhibit interleukin-17A and manage their active plaque psoriasis.
Crestor
0brand
We will start you on Crestor today to inhibit HMG-CoA reductase and significantly lower your LDL-C levels.
Cymbalta
0brand
We can start the patient on Cymbalta at thirty milligrams daily to help manage her generalized anxiety disorder.
Cypsedo
0brand
We selected Cypsedo for the induction of general anesthesia because of its positive modulation at GABAA receptors.
Datroway
0brand
Because Datroway functions as a Trop-2-directed antibody-drug conjugate, we will administer it via intravenous infusion every three weeks.
Decnupaz
0brand
We will administer Decnupaz as an intravenous infusion every three weeks to target CD123 in this patient with BPDCN.
Dupixent
0brand
We should start Dupixent by subcutaneous injection to target the IL-4Rα subunit and better control your severe asthma.
Ebglyss
0brand
We can initiate Ebglyss via subcutaneous injection to specifically target interleukin-13 signaling for this patient with moderate-to-severe atopic dermatitis.
Eliquis
0brand
We should start the patient on Eliquis twice daily to reduce their risk of stroke from nonvalvular atrial fibrillation.
Elrexfio
0brand
Before administering Elrexfio for multiple myeloma, ensure the patient receives premedications to mitigate the risk of cytokine release syndrome.
Enbrel
0brand
We can initiate Enbrel as a weekly subcutaneous injection to help reduce joint inflammation from your rheumatoid arthritis.
Ensacove
0brand
Before starting Ensacove for your metastatic NSCLC, we need to check your baseline liver function tests and fasting blood glucose.
Entresto
0brand
Let's initiate Entresto today to manage the patient's heart failure by combining a neprilysin inhibitor with an angiotensin receptor blocker.
Farxiga
0brand
As an SGLT2 inhibitor, Farxiga works by promoting urinary glucose excretion to help improve glycemic control in type 2 diabetes.
Flonase
0brand
Start using two sprays of Flonase in each nostril daily to effectively manage your persistent nasal congestion.
Foundayo
0brand
Foundayo is an oral GLP-1 receptor agonist that we will gradually titrate monthly to help regulate your appetite and support weight loss.
acetaminophen (generic)
1generic
You can take acetaminophen every six hours to help reduce your fever and relieve minor muscular aches.
acoltremon (generic)
1generic
We prescribed TRYPTYR because acoltremon targets ocular TRPM8 thermoreceptors to help stimulate natural basal tear production.
acoramidis (generic)
1generic
We should initiate acoramidis for this patient since it functions as a selective stabilizer of transthyretin tetramers.
adalimumab (generic)
1generic
Adalimumab works by binding specifically to TNF-alpha to help reduce systemic inflammation and control your rheumatoid arthritis symptoms.
alprazolam (generic)
1generic
We can start alprazolam at a low dose to manage your generalized anxiety disorder and slowly titrate if needed.
apixaban (generic)
1generic
We are starting the patient on oral apixaban to reduce their risk of stroke associated with nonvalvular atrial fibrillation.
apremilast (generic)
1generic
Let's begin oral apremilast today, as its targeted inhibition of phosphodiesterase 4 should help manage your chronic symptoms.
aripiprazole (generic)
1generic
Because aripiprazole acts as a partial agonist at D2 receptors, we should start this patient with schizophrenia at ten milligrams daily.
atacicept-vymj (generic)
1generic
By dual-targeting BAFF and APRIL, atacicept-vymj effectively lowers pathogenic galactose-deficient IgA1 levels in patients with IgAN.
atogepant (generic)
1generic
Starting the patient on atogepant is appropriate because this calcitonin gene-related peptide receptor antagonist effectively reduces migraine frequency.
atorvastatin (generic)
1generic
We should start the patient on daily oral atorvastatin to inhibit HMG-CoA reductase and effectively lower their elevated LDL-C levels.
baloxavir marboxil (generic)
1generic
We chose baloxavir marboxil for this patient because it halts influenza virus replication by targeting the viral endonuclease activity.
baxdrostat (generic)
1generic
We are initiating baxdrostat to selectively target aldosterone synthase and achieve better blood pressure control.
bevacizumab-vikg (generic)
1generic
We are initiating bevacizumab-vikg therapy today to inhibit retinal neovascularization and help stabilize the patient's visual acuity.
bictegravir, emtricitabine, and tenofovir alafenamide (generic)
1generic
Your doctor has prescribed bictegravir, emtricitabine, and tenofovir alafenamide for your condition.
budesonide and formoterol fumarate dihydrate (generic)
1generic
I recommend starting budesonide and formoterol fumarate dihydrate twice daily to provide both anti-inflammatory control and bronchodilation for your asthma.
bulevirtide-gmod (generic)
1generic
We plan to start the patient on bulevirtide-gmod today, as this antiviral drug will help target their viral infection.
canakinumab (generic)
1generic
We are starting the patient on canakinumab to selectively neutralize IL-1β and suppress their systemic inflammatory response.
cariprazine (generic)
1generic
We chose cariprazine for this patient because its partial agonist activity at dopamine D2 receptors helps manage psychiatric symptoms effectively.
cefepime and zidebactam (generic)
1generic
Let's initiate cefepime and zidebactam because the addition of a beta-lactamase inhibitor will help overcome this resistant Gram-negative infection.
centanafadine (generic)
1generic
We can trial centanafadine for this adult's ADHD since its mechanism involves inhibiting norepinephrine, dopamine, and serotonin reuptake transporters.
cetirizine (generic)
1generic
You can take cetirizine once daily to help control your runny nose and sneezing caused by seasonal hay fever.
cipepofol (generic)
1generic
We selected Cypsedo for general anesthesia induction because cipepofol enhances inhibitory signaling at GABAA receptors.
clopidogrel (generic)
1generic
We should start clopidogrel immediately with a loading dose to inhibit platelet aggregation in this acute coronary syndrome patient.
concizumab (generic)
1generic
We are starting the patient on concizumab because targeting tissue factor pathway inhibitor helps manage their hemophilia despite existing inhibitors.
copper histidinate (generic)
1generic
We should initiate daily subcutaneous copper histidinate injections to bypass impaired absorption and treat the infant with Menkes disease.
dapagliflozin (generic)
1generic
We can start dapagliflozin at five milligrams daily to improve glycemic control by blocking glucose reabsorption in the proximal renal tubules.
datopotamab deruxtecan (generic)
1generic
We plan to start datopotamab deruxtecan today since this novel antibody-drug conjugate effectively delivers a potent topoisomerase I inhibitor to tumors.
diazepam (generic)
1generic
We should start oral diazepam to help manage this patient's acute alcohol withdrawal symptoms and reduce the risk of delirium tremens.
difamilast (generic)
1generic
Applying difamilast works by inhibiting phosphodiesterase-4, which elevates intracellular cyclic AMP levels to suppress inflammatory signaling.
dimethyl fumarate (generic)
1generic
We plan to start oral dimethyl fumarate to help reduce relapses and manage your multiple sclerosis symptoms.
diphenhydramine (generic)
1generic
Let's administer fifty milligrams of diphenhydramine intravenously as an adjunct to epinephrine following the patient's acute anaphylaxis.
doravirine and islatravir (generic)
1generic
We can switch the patient to doravirine and islatravir to effectively suppress HIV-1 replication with this novel antiretroviral combination regimen.
dulaglutide (generic)
1generic
Because dulaglutide acts as a GLP-1 receptor agonist, it effectively stimulates glucose-dependent insulin release from pancreatic beta cells.
duloxetine (generic)
1generic
We can initiate oral duloxetine at thirty milligrams daily to help manage your chronic musculoskeletal pain while minimizing potential side effects.
dupilumab (generic)
1generic
We are starting dupilumab to target the IL-4Rα subunit and reduce the patient's recurring airway inflammation.
durvalumab (generic)
1generic
We are starting the patient on durvalumab, a monoclonal antibody that targets PD-L1 to restore cytotoxic T-cell activity against the tumor.
efgartigimod alfa (generic)
1generic
Because efgartigimod alfa targets the neonatal Fc receptor, we should monitor the patient for a significant reduction in circulating IgG levels.
elexacaftor, tezacaftor, and ivacaftor (generic)
1generic
Starting elexacaftor, tezacaftor, and ivacaftor will help facilitate CFTR protein trafficking and restore essential chloride transport.
elranatamab-bcmm (generic)
1generic
We are starting elranatamab-bcmm today to target BCMA and induce T-cell mediated lysis of refractory multiple myeloma cells.
empagliflozin (generic)
1generic
Starting empagliflozin will selectively block SGLT2 transporters in the kidneys, which directly promotes urinary glucose excretion.
enlicitide decanoate (generic)
1generic
We can initiate enlicitide decanoate to target PCSK9 and help lower your circulating low-density lipoprotein levels effectively.
ensartinib (generic)
1generic
We should consider ensartinib for this patient because it effectively targets anaplastic lymphoma kinase and blocks downstream tumor proliferation.
ensitrelvir (generic)
1generic
We are starting ensitrelvir to target the SARS-CoV-2 main protease and stop active viral replication in this patient.
esomeprazole (generic)
1generic
We will start esomeprazole once daily to inhibit the H+/K+ ATPase enzyme system and relieve your symptomatic GERD.
etanercept (generic)
1generic
We should start the patient on etanercept today to help block TNF and reduce the severe joint inflammation.
exagamglogene autotemcel (generic)
1generic
We plan to administer exagamglogene autotemcel to suppress BCL11A expression and prevent painful vaso-occlusive crises in our sickle cell patient.
exenatide (generic)
1generic
As a GLP-1 receptor agonist, exenatide enhances glucose-dependent insulin secretion to improve blood sugar levels in type 2 diabetes.
famotidine (generic)
1generic
We can start you on oral famotidine at bedtime to competitively inhibit histamine-2 receptors and reduce gastric acid secretion.
faricimab-svoa (generic)
1generic
We chose faricimab-svoa because this bispecific antibody simultaneously targets VEGF-A and Ang-2 to help reduce vascular permeability.
fezolinetant (generic)
1generic
We can initiate fezolinetant today because this neurokinin 3 receptor antagonist effectively targets neuronal activity in the thermoregulatory center.
fluoxetine (generic)
1generic
We will start the patient on oral fluoxetine every morning to effectively manage their ongoing major depressive disorder.
fluticasone propionate (generic)
1generic
You can use fluticasone propionate once daily in each nostril to relieve stubborn nasal congestion caused by your allergies.
fluticasone propionate and salmeterol (generic)
1generic
We are starting fluticasone propionate and salmeterol twice daily to control persistent airway inflammation and relax bronchial smooth muscle.
gadoquatrane (generic)
1generic
Administering gadoquatrane enhances tissue signal intensity during the scan by effectively altering the relaxation rates of local water protons.
gedatolisib (generic)
1generic
Adding gedatolisib helps target both PI3K and mTOR complexes to slow tumor growth in ER-positive breast cancer.
gepotidacin (generic)
1generic
We can initiate gepotidacin for this patient once we confirm the bacterial source of the infection.
ibuprofen (generic)
1generic
You can take ibuprofen every four to six hours to help relieve the pain caused by your menstrual cramps.
End of preview. Expand in Data Studio

DOSE v1.0: Drug-name Oral Synthesis Evaluation

Can your voice model say retatrutide?

DOSE is a benchmark measuring how accurately text-to-speech (TTS) systems pronounce pharmaceutical drug names. It covers established brands, newly-approved names, and generic/INN names, each tested inside a real clinical sentence rather than spoken in isolation.

Version: DOSE v1.0. Live leaderboard and five public audio samples: https://synthiolabs.com/synthio-dose-benchmark

This public dataset is the held-out test set only: drug name, name type, and clinical sentence. Reference pronunciations, evaluation audio, and per-system scores are not released, so the set cannot be used as an answer key. Email rohit@synthiolabs.com to submit a model for scoring.

Why this matters

Mispronounced drug names in voice AI (IVR systems, clinical voice agents, pharmacy assistants) are a patient-safety concern analogous to LASA (Look-Alike/Sound-Alike) drug name confusion — a recognized WHO/ISMP/FDA error category. As voice AI is deployed further into clinical workflows, TTS mispronunciation of a drug name is a new, largely unmeasured extension of that same risk category.

Quickstart

from datasets import load_dataset

ds = load_dataset("SynthioLabs/dose-benchmark", split="train")

row = ds[0]
print(row["drug"], row["name_type"], row["sentence"])

Filter by name type:

generic_names = ds.filter(lambda r: r["name_type"] == "generic")
brand_names = ds.filter(lambda r: r["name_type"] == "brand")

Dataset

  • 274 drug names: 128 traditional (established) + 146 new (recently approved) names. One row per name.
  • Brand and generic/INN names (name_type column).
  • 9 TTS systems were evaluated on these sentences (see leaderboard). Those recordings and scores are not in this download.
  • Every system read the exact same clinical sentence containing the drug name, with no special pronunciation hints given to any system.

How DOSE is scored

Reference pronunciations. Each drug’s reference comes from public pharmaceutical sources, including labels, manufacturer materials, and established medical references. It is then checked against spoken clinical usage so the target reflects the accepted pronunciation — not a model’s guess. The reference strings themselves are held out.

Judge. Each system’s recording is scored 0–5 against that same reference by automated audio comparison. Several independent judgments are combined into one result; 4 or higher counts as a pass. Human reviewers are not in the scoring loop.

Columns

Column Type Description
drug string Drug name (brand or generic/INN)
name_type class label brand or generic
sentence string The clinical sentence to be read aloud

Leaderboard (overall pass rate, score >= 4)

Rank System Model Pass rate
1 Synthio Synthio RxPronounce 91.2%
2 Cartesia sonic-3.6 (beta) 80.3%
3 ElevenLabs eleven_v3 79.2%
4 OpenAI TTS gpt-4o-mini-tts 77.4%
5 xAI Grok TTS 77.0%
6 Google (Gemini TTS) gemini-3.1-flash-tts-preview 74.5%
7 Deepgram aura-2-thalia-en 72.6%
8 Cartesia sonic-3.5 69.0%
9 Microsoft Azure DragonHD Neural 63.1%

Submit your model

Email us at rohit@synthiolabs.com to submit a model for evaluation.

Citation

@misc{synthio2026dosev1,
  title   = {DOSE v1.0: Drug-name Oral Synthesis Evaluation},
  author  = {Pari, Rohit Gangadhar and {Synthio Labs}},
  year    = {2026},
  url     = {https://synthiolabs.com/synthio-dose-benchmark}
}
Downloads last month
39